CFTR and cystic fibrosis: Ongoing efforts to rationalize the molecular basis for the diverse responses of clinical CF variants to various CFTR modulators have revealed that pharmacological responses coincide with changes in the CFTR interactome (Iazzi et al., 2022; Louie et al., 2012; McDonald et al., 2022a; Kim et al., 2023).